Table 1 Clinical and epidemiological characteristics of the 473 COVID-19 patients in Wenzhou, China
From: Transmission dynamics of SARS-CoV-2 in a mid-size city of China
Early clinical symptoms | Wenzhou |
|---|---|
n/ (%) | |
Female sex | 222 (48.4) |
Age, Median (range)—years | 47.6 (2–93) |
Travel or residence history within 14Â days | Â |
 Recently been to Wuhan | 160 (33.8) |
 Outside Wuhan or Wenzhou in China | 24 (5.1) |
 Wenzhou | 289 (61.1) |
Contact with source of transmission within 14Â days | Â |
 Contacted with people from Wuhan | 36 (7.6) |
 Contacted with patient | 195 (41.2) |
 Related the Yintai world trade center | 17 (3.6) |
 Undiscovered source of transmission | 61 (12.9) |
 Unknown | 164 (34.7) |
Symptoms | Â |
 Asymptoms | 23 (4.9) |
Symptoms | Â |
 Fever | 339 (71.7) |
 Headache | 31 (6.6) |
 Cough | 204 (43.1) |
 Sore throat | 39 (8.2) |
 Sputum production | 50 (10.6) |
 Fatigue | 57 (12.1) |
 Diarrhea or appetite loss | 15 (3.2) |
 Muscle soreness | 29 (6.1) |
Disease severity | Â |
 Severe | 51 (10.8) |
Clinical outcomes | Â |
 Discharge from hospital | 472 (99.8) |
 Death | 1 (0.2) |
Time from onset to diagnosis (days) | Â |
 Median (range) | 6.0 (0–23) |